Skip to main content
Premium Trial:

Request an Annual Quote

Aclara, Punished by Lawsuit Settlement Costs, Posts Bruising Q2 Losses

NEW YORK, Aug. 1 - Aclara Biosciences reported a reduction in total second-quarter revenue atop increased R&D spending and a significantly widened net loss.

For the three months ended June 30, Aclara reported total revenues of $673,000 compared with $849,000 for the same period one year ago. R&D spending in the quarter increased to $6.4 million from $5.5 million year over year. In addition, the company was forced to shell out $1.8 million as part of a settlement of a lawsuit with with Caliper Technologies last January.

As a result, net loss in the quarter ballooned to $9.9 million, or $.27 per share, from $3.2 million, or $.09 per share, in the second quarter 2001, Aclara said.


Aclara, which yesterday said announced plans to lay off 50 of its staff as it redirects its business strategy away from microfluidics, had roughly $45.8 million in cash and cash equivalents as of June 30.


Click here for more information.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.